Advertisement
Advertisement
U.S. Markets open in 1 hr 21 mins
Advertisement
Advertisement
Advertisement
Advertisement

Predictive Oncology Inc. (POAI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3051-0.0308 (-9.17%)
At close: 04:00PM EDT
0.3300 +0.02 (+8.16%)
Pre-Market: 08:06AM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/20/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.6400
52 Week Low 30.3050
50-Day Moving Average 30.8126
200-Day Moving Average 30.9731

Share Statistics

Avg Vol (3 month) 3546.47k
Avg Vol (10 day) 31.76M
Shares Outstanding 565.58M
Implied Shares Outstanding 6N/A
Float 863.42M
% Held by Insiders 14.06%
% Held by Institutions 17.38%
Shares Short (Apr 28, 2022) 4728.02k
Short Ratio (Apr 28, 2022) 42.82
Short % of Float (Apr 28, 2022) 41.15%
Short % of Shares Outstanding (Apr 28, 2022) 41.10%
Shares Short (prior month Mar 30, 2022) 4936.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 28, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Oct 28, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-948.25%

Management Effectiveness

Return on Assets (ttm)-29.63%
Return on Equity (ttm)-91.62%

Income Statement

Revenue (ttm)1.42M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)62.20%
Gross Profit (ttm)933.66k
EBITDA -12.13M
Net Income Avi to Common (ttm)-19.66M
Diluted EPS (ttm)-0.5440
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.2M
Total Cash Per Share (mrq)0.43
Total Debt (mrq)879.33k
Total Debt/Equity (mrq)2.18
Current Ratio (mrq)9.09
Book Value Per Share (mrq)0.73

Cash Flow Statement

Operating Cash Flow (ttm)-12.21M
Levered Free Cash Flow (ttm)-9M
Advertisement
Advertisement